Szczylik C, Wiktor-Jedrzejczak W
Allerg Immunol (Leipz). 1981;27(3):162-7.
Results of the PHA skin test correlate with prognosis of cancer patients (W. Wiktor-Jedrzejczak [17] ). However, its clinical interpretation is faded by not known character of this reaction. In the present study PHA skin test was performed on 50 subjects simultaneously with: 1. sealed capillary migration inhibition test in the presence of various concentrations of PHA; 2. E and EAC rosette tests for quantitation of T and B lymphocytes. Skin reaction to 1 microgram of purified PHA (Wellcome) was found to correlate with migration inhibition performed using suboptimal doses of PHA-P (Difco). -No correlation was found between leukocyte and lymphocyte absolute count and PHA skin test. Neither proportions nor absolute numbers of E+, and EAC+ and null cells correlated with PHA skin test. On several occasions the test persisted positive despite absence of lymphocytes in peripheral blood of patients. -These studies further suggest that PHA skin test has certain characteristics similar to DTH reactions and that changes of the test do not simply reflect changes in PBL subpopulations.
PHA皮肤试验的结果与癌症患者的预后相关(W. Wiktor-Jedrzejczak [17])。然而,由于这种反应的性质尚不清楚,其临床意义有所减弱。在本研究中,对50名受试者同时进行了PHA皮肤试验以及:1. 在不同浓度PHA存在下的密封毛细血管迁移抑制试验;2. 用于定量T和B淋巴细胞的E和EAC玫瑰花结试验。发现对1微克纯化PHA(惠康公司)的皮肤反应与使用次优剂量的PHA-P(Difco)进行的迁移抑制相关。白细胞和淋巴细胞绝对计数与PHA皮肤试验之间未发现相关性。E+、EAC+和空细胞的比例及绝对数量均与PHA皮肤试验无关。有几次,尽管患者外周血中没有淋巴细胞,但试验仍持续呈阳性。这些研究进一步表明,PHA皮肤试验具有某些与迟发型超敏反应相似的特征,并且试验的变化并不简单地反映外周血淋巴细胞亚群的变化。